STXI ETF Analysis

Esta página fue traducida automáticamente del original en inglés mediante IA; la versión en inglés es la autorizada. Leer la versión en inglés

Solo con fines informativos. No es asesoramiento financiero.

Respuesta Rápida

In the stored portfolio snapshot dated Mar 15, 2026, the largest listed holding is ASML Holding NV (ASML.AS) at 2.94%.

STXI ETF — Price, Holdings & Analysis

Descripción general del ETF

STXI aims to replicate the performance of an index comprised of a small selection of global stocks. The ETF achieves this by investing in the constituent companies of the underlying index, weighting them according to their index representation. STXI offers a concentrated approach to global equities, potentially leading to higher volatility compared to more diversified ETFs. The fund's top holdings include ASML Holding NV (2.94%), Novartis AG Registered Shares (1.77%), and Roche Holding AG (1.77%). Other significant allocations include HSBC Holdings PLC (1.71%) and AstraZeneca PLC (1.67%). This concentrated portfolio may appeal to investors seeking targeted exposure to specific global companies rather than broad market diversification. STXI's strategy is suited for investors with a higher risk tolerance seeking concentrated exposure.

Métricas de riesgo

STXI's presents a significant concentration risk. A downturn in any of its top holdings, such as ASML Holding NV, Novartis AG, or Roche Holding AG, could disproportionately impact the ETF's performance. The ETF's three-year beta of 0.00 suggests it has historically exhibited very low volatility relative to the market. However, this may not hold true in all market conditions, especially given the concentrated nature of its holdings. Investors should carefully consider their risk tolerance and investment objectives before investing in STXI, acknowledging the potential for amplified volatility due to its concentrated nature. Past performance does not guarantee future results.

Beta: 0.00

¿Qué contiene STXI?

Participación	Peso
ASML Holding NV (ASML.AS)	2.94%
Novartis AG Registered Shares (NOVN.SW)	1.77%
Roche Holding AG (ROG.SW)	1.77%
HSBC Holdings PLC (HSBA.L)	1.71%
AstraZeneca PLC (AZN.L)	1.67%
Nestle SA (NESN.SW)	1.49%
Toyota Motor Corp (7203.T)	1.33%
Shell PLC (SHEL.L)	1.26%
Siemens AG (SIE.DE)	1.20%
Royal Bank of Canada (RY)	1.18%

Participaciones y ponderaciones a 15 mar 2026. Estos datos del fondo tienen más de 45 días; verifique las participaciones actuales con el emisor.

Rentabilidad por dividendo

0.00%

Preguntas y respuestas

What is STXI and what does it track?

STXI is an exchange-traded fund (ETF) designed to track the performance of a specific index composed of a small selection of global stocks.

The ETF provides investors with a way to gain exposure to these companies through a single investment vehicle. As of 2026-03-15, with top allocations including ASML Holding NV, Novartis AG, and Roche Holding AG.

What are the top holdings in STXI?

As of 2026-03-15, the top five holdings in STXI are: 1) ASML Holding NV (ASML.AS) at 2.94%, 2) Novartis AG Registered Shares (NOVN.SW) at 1.77%, 3) Roche Holding AG (ROG.SW) at 1.77%, 4) HSBC Holdings PLC (HSBA.L) at 1.71%, and…

5) AstraZeneca PLC (AZN.L) at 1.67%.

Is STXI a good long-term investment?

Whether STXI is a suitable long-term investment depends on an investor's individual circumstances, risk tolerance, and investment objectives. The ETF's may lead to higher volatility compared to more diversified options.

As of 2026-03-15, STXI has a dividend yield of 0.00% and a three-year beta of 0.00. Investors should carefully consider these factors and conduct thorough research before making any investment decisions. Past performance does not guarantee future results.

How does STXI compare to similar ETFs?

However, STXI's defining characteristic is its highly. Many similar ETFs tracking global equities will hold a much larger number of companies, providing greater diversification.

Investors should compare STXI's expense ratio (not available in provided data), AUM, and investment strategy to those of other global equity ETFs to determine which fund best aligns with their needs. The level of concentration is a key differentiator.

Does STXI pay dividends?

As of 2026-03-15, STXI exhibits a dividend yield of 0.00%. This indicates that the ETF is not currently distributing any dividend income to its shareholders. Investors seeking dividend income may want to consider alternative ETFs with a higher dividend yield.

However, dividend yield is only one factor to consider when evaluating an ETF's overall suitability.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Datos proporcionados solo con fines informativos.

Escrito por una máquina, sin revisión página por página. La supervisión editorial es sistémica: se comprueban las reglas y las fuentes, no cada página.